Education
About Us
Working with TipRanks
Follow Us
PT Kalbe Farma Tbk (PTKFY)
OTHER OTC:PTKFY
PTKFY Stock Chart & Stats
$14.38
$0.00(0.00%)
At close: 4:00 PM EST
$14.38
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$12.36 - $19.68
Previous CloseN/A
Volume58.00
Average Volume (3M)154.00
Market Cap
$3.36B
Enterprise Value$4.18B
Total Cash (Recent Filing)$3.95T
Total Debt (Recent Filing)$779.98B
Price to Earnings (P/E)15.3
Beta0.51
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.35%
Share Statistics
EPS (TTM)0.18
Shares Outstanding234,066,960
10 Day Avg. Volume0
30 Day Avg. Volume154
Financial Highlights & Ratios
PEG Ratio1.37
Price to Book (P/B)3.38
Price to Sales (P/S)2.36
P/FCF Ratio21.81
Enterprise Value/Market Cap1.24
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PT Kalbe Farma Tbk News
PTKFY FAQ
What was PT Kalbe Farma Tbk’s price range in the past 12 months?
PT Kalbe Farma Tbk lowest stock price was $12.36 and its highest was $19.68 in the past 12 months.
What is PT Kalbe Farma Tbk’s market cap?
PT Kalbe Farma Tbk’s market cap is $3.36B.
When is PT Kalbe Farma Tbk’s upcoming earnings report date?
PT Kalbe Farma Tbk’s upcoming earnings report date is Mar 26, 2026 which is in 98 days.
How were PT Kalbe Farma Tbk’s earnings last quarter?
PT Kalbe Farma Tbk released its earnings results on Oct 28, 2025. The company reported $0.176 earnings per share for the quarter, beating the consensus estimate of N/A by $0.176.
Is PT Kalbe Farma Tbk overvalued?
According to Wall Street analysts PT Kalbe Farma Tbk’s price is currently Overvalued.
Does PT Kalbe Farma Tbk pay dividends?
PT Kalbe Farma Tbk pays a Annually dividend of $0.442 which represents an annual dividend yield of 3.35%. See more information on PT Kalbe Farma Tbk dividends here
What is PT Kalbe Farma Tbk’s EPS estimate?
PT Kalbe Farma Tbk’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PT Kalbe Farma Tbk have?
PT Kalbe Farma Tbk has 234,066,960 shares outstanding.
What happened to PT Kalbe Farma Tbk’s price movement after its last earnings report?
PT Kalbe Farma Tbk reported an EPS of $0.176 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.365%.
Which hedge fund is a major shareholder of PT Kalbe Farma Tbk?
Currently, no hedge funds are holding shares in PTKFY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
PT Kalbe Farma Tbk Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-33.75%
12-Months-Change
Fundamentals
Return on Equity
15.61%
Trailing 12-Months
Asset Growth
3.35%
Trailing 12-Months
Company Description
PT Kalbe Farma Tbk
PT Kalbe Farma Tbk (PTKFY) is one of the largest pharmaceutical companies in Indonesia, operating primarily in the healthcare sector. Founded in 1966, the company is involved in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products, including prescription drugs, over-the-counter products, nutritional supplements, and herbal medicines. Kalbe Farma also has a significant presence in the distribution of its products, serving both local and international markets.
Technical Analysis
Grifols SA
―
SRx Health Solutions
―
Scilex Holding Company
―
Organon
―
Citius Oncology
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.03% Other Institutional Investors
99.97% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---